SKI Market

Indian Indices

Sensex

83,570.35 187.64
( 0.23%)

Global Indices

Nasdaq

49,379.59 -83.86
(-0.17%)

Dow Jones

6,960.70 -4.77
(-0.07%)

Hang Seng

53,996.71 -113.79
(-0.21%)

Nikkei 225

10,219.48 -19.46
(-0.19%)

Forex

USD-INR

90.32 0.07
(0.08%)

EUR-INR

104.98 -0.13
(-0.12%)

GBP-INR

121.10 -0.20
(-0.16%)

JPY-INR

0.57 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Colinz Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

531210

INE923C01011

26.0966966

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

47.42

21.89

EPS(TTM)

Face Value()

Div & Yield %

1.01

Back

exide industries ltd

Board of Suraj recommends Interim Dividend

Jan 16,2026

Suraj announced that the Board of Directors of the Company at its meeting held on 16 January 2025, has recommended a Interim Dividend of Rs.1.50 per share (i.e.15%), subject to the approval of the shareholders.

83,570.35 187.64 ( 0.23%)

49,379.59 -83.86 (-0.17%)

6,960.70 -4.77 (-0.07%)

53,996.71 -113.79 (-0.21%)

10,219.48 -19.46 (-0.19%)

90.32 0.07 (0.08%)

104.98 -0.13 (-0.12%)

121.10 -0.20 (-0.16%)

0.57 0.00 (0.21%)